Antares, Teva File sNDA for Human Growth Hormone

Antares Pharma, Inc, a specialty pharmaceutical company focused on improving pharmaceuticals through advanced drug delivery systems, and its partner, Teva Pharmaceutical Industries announced the filing of a Supplemental New Drug Application (sNDA) in order to add “needle-free injection” to the product drug label.
The Earth Times